A STUDY ON PROBLEMS AND PROSPECTS OF INTELLECTUAL PROPERTY RIGHTS IN INDIANPHARMACEUTICAL INDUSTRY
DOI:
https://doi.org/10.61841/369jfr43Keywords:
Intellectual Property Rights, Patent, Research and Development, ClinicalTrials, Copyrights, Generics DrugsAbstract
Ideas, innovations, and creative expressions based on which the public is ready to confer the status of property have been classified as intellectual property rights (IPR). IPR give the inventors or developers of a property certain exclusive rights in order for them to profit commercially from their creative work or reputation. Intellectual property protection comes in many forms, including patents, copyright, trademarks, and so on. A patent is granted to an invention that meets the requirements of worldwide novelty, non-obviousness, and industrial applicability. IPR is required for better invention or creativity identification, planning, marketing, rendering, and therefore protection. Depending on its field of expertise, each industry should have its own IPR rules, management style, strategies, and so on. In the approaching period, the pharmaceutical industry's expanding IPR strategy will require a greater focus and approach. The pharmaceutical sector in India is expanding at a quicker pace. Indian pharma companies, on the other hand, are looking for worldwide commercial prospects like as export, contract research, and clinical trials. Intellectual Property Rights have become more important to many Indian businesses. The amount of money spent on research and development is likewise increasing. From their initial investment to strengthen their R&D to obtaining patent and other IP protection for their new breakthroughs, Indian pharmaceutical businesses confront numerous hurdles. Many legal formalities must be completed for drug discovery, paperwork, and clinical trials, among other things. The key issues confronting Indian pharmaceutical companies include the high cost of investment, the expiration of patented pharmaceuticals, the absence of clinical studies, the increased legal formalities, and the difficulties in getting IP protection.This research focused on both the issues that companies face as well as the opportunity that IPR provides for Indian pharmaceutical companies. The prevalent challenges related with IPR, particularly in relation to Indian pharmaceutical companies, provided a wider potential for this research. It is unavoidable that Indian pharmaceutical businesses will wish to safeguard their innovation through patents when they begin to invest more heavily in R&D and produce their own compounds that can be patented. As a result, the Indian government should promote and safeguard multinational company patents as well. Patents and other kinds of intellectual property (IP) rights are critical for industry and research and development. Businesses, particularly pharmaceutical companies, are unable to invest in R&D or produce new, creative treatments without robust protections.
Downloads
References
1. Singh R. Vol. 1. New Delhi: Universal Law Publishing Co. Pvt. Ltd; 2004. Law relating to intellectual property (A complete comprehensive material on intellectual property covering acts, rules, conventions, treaties, agreements, case law and much more).
2. Anonymous. New Delhi: Department of Science and Technology (DST), Government of India; 2002. Research and development statistics.
3. Anonymous. New Delhi: Department of Scientific and Industrial Research, Government of India; 2002. Research and development in industry: An overview.
4. Bainbridge DI. New York: Longman; 2002. Intellectual property.
5. Anonymous. New Delhi: Universal Law Publishing Co. Ltd; 2004. The Design Act, 2000 along with Design Rules 2001.
6. Anonymous. New Delhi: Commercial Law Publisher (India) Pvt. Ltd; 2004. The Trademarks Act 1999 along with Trade Marks Rules 2002.
7. Anonymous. New Delhi: Commercial Law Publisher (India) Pvt. Ltd; 2005. The Copyright Act 1957 as amended up to 1999 along with Copyright Rules 1958 and International Copyright Order 1999.
8. Anonymous. New Delhi: Universal Law Publishing Co. Ltd; 2004. The Geographical Indications of Goods (Registration and Protection) Act, 1999 along with Geographical Indications of Goods (Registration and Protection) Rules 2002.
9. Anonymous. New Delhi: Commercial Law Publisher (India) Pvt. Ltd; 2005. The Patents Act, 1970 as amended by Patents (Amendment) Act 2005.
10. Michaels A. 2nd ed. London: Sweet and Maxwell; 1996. A practical guide to Trade Mark Law.
11. Watal J. London: Kluwer Law International; 2001. Intellectual property rights in the WTO and developing countries.
12. Abbott F, Cottier T, Gurry F. London: Kluwer Law International; 1999. The international intellectual property system: Commentary and materials. Part I.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
